作者: Christopher Sears , Scott A. Armstrong
DOI: 10.1016/S0065-230X(06)96003-5
关键词:
摘要: Over the past decade, microarrays have emerged as an important tool for characterization of cancer cells. Numerous studies demonstrated that cDNA arrays can help delineate biological subsets disease prognostic relevance. Such provide hope introduction this information into clinical trials will lead to more biologically based stratification schemes such appropriately tailored therapies be developed. While identification unique promises improve our ability predict which cancers are unlikely a significant response therapy, new therapeutic approaches needed in most cases. The wealth comes from microarray analysis likely holds necessary develop approaches. This chapter examples where has been used attempt either direct use current or identify potential avenues.